Strangely Grifols shareholders don't seem too worried... and they have a bigger % of sales from CIDP that we do. Although admittedly the emphasis there is more on digging themselves out from under a pile of debt and the P/E is quite a bit lower.
UBS - CSL no need to worry about Argenx, page-17
Add CSL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$301.85 |
Change
0.340(0.11%) |
Mkt cap ! $145.9B | |||
| Open | High | Low | Value | Volume |
| $303.22 | $303.24 | $301.72 | $7.693M | 25.38K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 14 | $301.81 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $302.22 | 74 | 3 |
View Market Depth
| Last trade - 10.05am 11/09/2024 (20 minute delay) ? |
| CSL (ASX) Chart |